Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Jan 1;48(1):67-71.
doi: 10.1097/DSS.0000000000003220.

Bleomycin Electrosclerotherapy Treatment in the Management of Vascular Malformations

Milosz Kostusiak  1 , Srinivasen Murugan, Tobian Muir
Affiliations
Observational Study

Bleomycin Electrosclerotherapy Treatment in the Management of Vascular Malformations

Milosz Kostusiak et al. Dermatol Surg. .

Abstract

Background: Intralesional injection of a sclerosing agent is a standard treatment for vascular malformations, but many repeat treatments are often required to achieve a response. The temporary application of an electrical field to the treated area increases cellular membrane permeability and therefore augments drug delivery.

Objective: To report a case series of patients with vascular malformations who received bleomycin electrosclerotherapy (EST).

Materials and methods: A prospective observational case series of patients with vascular malformations treated with bleomycin EST. Only patients who did not respond or had limited response to standard sclerotherapy were included. The response to the treatment was assessed using a global assessment score and patient-reported outcome measures.

Results: Thirty patients were treated with EST. Most of the patients had venous malformations (57%). Complete response or significant improvement was observed in 17 (57%) and 7 (23%) patients, respectively. Most of the patients were satisfied or very much satisfied with the outcome of the treatment. Most commonly reported complications were swelling, pain, and bleeding.

Conclusion: Electrosclerotherapy is a promising method of augmenting the efficacy of intralesional bleomycin injections when treating vascular malformations. It can potentially lead to a reduction in the administered dose and number of treatment sessions needed.

PubMed Disclaimer

References

    1. Eifert S, Villavicencio JL, Kao TC, Taute BM, et al. Prevalence of deep venous anomalies in congenital vascular malformations of venous predominance. J Vasc Surg 2000;31:462–71.
    1. Tasnádi G. Epidemiology of vascular malformations. In: Hemangiomas and Vascular Malformations: An Atlas of Diagnosis and Treatment. Milano: Springer Milan; 2009; pp. 109–10.
    1. Lee B-B, Laredo J, Neville RF, Kim Y-W, et al. Epidemiology of vascular malformations. In: Hemangiomas and Vascular Malformations. Milano: Springer Milan; 2015; pp. 165–9.
    1. Horbach SE, Lokhorst MM, Saeed P, de Goüyon Matignon de Pontouraude CM, et al. Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg 2016;69:295–304.
    1. Colletti G, Valassina D, Bertossi D, Melchiorre F, et al. Contemporary management of vascular malformations. J Oral Maxillofac Surg 2014;72:510–28.

Publication types

LinkOut - more resources